Skip to main content
Clinical Trials/NCT03814161
NCT03814161
Unknown
Not Applicable

FRailty Among Elderly Emergency Department Patients With Outcome Measures

National University Hospital, Singapore1 site in 1 country211 target enrollmentJanuary 20, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Geriatric, Frailty, Emergency Department
Sponsor
National University Hospital, Singapore
Enrollment
211
Locations
1
Primary Endpoint
1-month Adverse Event Occurrence (composite)
Last Updated
4 years ago

Overview

Brief Summary

Our study aims to compare 4 clinical frailty scores, namely Clinical Frailty Scale (CFS), Edmonton Frail Scale (EFS), FRAIL 5-item scale (FRAIL) and SARC-F Sarcopenia Score (SARC-F), which can potentially be adopted for daily practice in the busy ED. It is timely as we projected that we will be seeing more elderly patients attending the ED for various medical and surgical conditions. Their attendance at the ED would be a good opportunity to screen for frailty among them, and to intervene to prevent adverse outcomes such as ED re-attendance or subsequent hospitalisation that might lead to poor functional outcomes and higher dependence on step-down care facilities.

Registry
clinicaltrials.gov
Start Date
January 20, 2019
End Date
December 1, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Elderly patients aged 65 years and above attending ED irrespective of reason for attendance.

Exclusion Criteria

  • Haemodynamically unstable patients
  • Inability to obtain informed consent
  • Inability to obtain reliable information from patient or caregiver (e.g. deafness, blindness, language barriers)
  • Vulnerable populations (e.g. prisoners)
  • Patients who are planned for hospital admission from the ED

Outcomes

Primary Outcomes

1-month Adverse Event Occurrence (composite)

Time Frame: At 1 month after index ED visit

Falls, ED re-attendance, hospital/ nursing home admission, decline in Activities of Daily Living and/or all-cause mortality

Secondary Outcomes

  • 3-month Adverse Event Occurrence (composite)(At 3 months after index ED visit)

Study Sites (1)

Loading locations...

Similar Trials